Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Ypsomed Holding AG

YPHDFPNK
Healthcare
Medical - Instruments & Supplies
$381.69
$0.00(0.00%)
U.S. Market opens in 1h 37m

Ypsomed Holding AG Fundamental Analysis

Ypsomed Holding AG (YPHDF) shows strong financial fundamentals with a PE ratio of 19.60, profit margin of 22.14%, and ROE of 30.14%. The company generates $0.9B in annual revenue with strong year-over-year growth of 10.25%.

Key Strengths

ROE30.14%
PEG Ratio0.25

Areas of Concern

Cash Position0.70%
We analyze YPHDF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 68.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
68.5/100

We analyze YPHDF's fundamental strength across five key dimensions:

Efficiency Score

Excellent

YPHDF demonstrates superior asset utilization.

ROA > 10%
17.38%

Valuation Score

Excellent

YPHDF trades at attractive valuation levels.

PE < 25
19.60
PEG Ratio < 2
0.25

Growth Score

Excellent

YPHDF delivers strong and consistent growth momentum.

Revenue Growth > 5%
10.25%
EPS Growth > 10%
50.26%

Financial Health Score

Excellent

YPHDF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.47

Profitability Score

Moderate

YPHDF maintains healthy but balanced margins.

ROE > 15%
30.14%
Net Margin ≥ 15%
22.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is YPHDF Expensive or Cheap?

P/E Ratio

YPHDF trades at 19.60 times earnings. This indicates a fair valuation.

19.60

PEG Ratio

When adjusting for growth, YPHDF's PEG of 0.25 indicates potential undervaluation.

0.25

Price to Book

The market values Ypsomed Holding AG at 5.10 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.10

EV/EBITDA

Enterprise value stands at 13.03 times EBITDA. This signals the market has high growth expectations.

13.03

How Well Does YPHDF Make Money?

Net Profit Margin

For every $100 in sales, Ypsomed Holding AG keeps $22.14 as profit after all expenses.

22.14%

Operating Margin

Core operations generate 17.65 in profit for every $100 in revenue, before interest and taxes.

17.65%

ROE

Management delivers $30.14 in profit for every $100 of shareholder equity.

30.14%

ROA

Ypsomed Holding AG generates $17.38 in profit for every $100 in assets, demonstrating efficient asset deployment.

17.38%

Following the Money - Real Cash Generation

Operating Cash Flow

Ypsomed Holding AG generates strong operating cash flow of $244.97M, reflecting robust business health.

$244.97M

Free Cash Flow

Ypsomed Holding AG generates weak or negative free cash flow of $-37.52M, restricting financial flexibility.

$-37.52M

FCF Per Share

Each share generates $-2.75 in free cash annually.

$-2.75

FCF Yield

YPHDF converts -0.91% of its market value into free cash.

-0.91%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

19.60

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.25

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.10

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.34

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.30

vs 25 benchmark

ROA

Return on assets percentage

0.17

vs 25 benchmark

ROCE

Return on capital employed

0.18

vs 25 benchmark

How YPHDF Stacks Against Its Sector Peers

MetricYPHDF ValueSector AveragePerformance
P/E Ratio19.6028.25 Better (Cheaper)
ROE30.14%780.00% Weak
Net Margin22.14%-20122.00% (disorted) Strong
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio1.474.66 Neutral
ROA17.38%-14687.00% (disorted) Strong

YPHDF outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ypsomed Holding AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

11.58%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

20.30%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

151.72%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ